Anti-miRNA oligonucleotides have shown effectiveness in inhibiting NF-κB in cancer.590 Targeting NF-κB signaling by ncRNAs is an emerging therapeutic strategy of cancer treatment. This evidence concerns the gene NFKB1 and cancer.